Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Govt Mulls New AMED Organ to Lead Strategic Funding for Vaccine Development
May 26, 2021
-
BUSINESS Sawai, Towa Post Domestic Sales Growth in FY2020, but Nichi-Iko Falters on GMP Violations: Jiho Tally
May 26, 2021
-
REGULATORY Japan Eyes Pfizer Vaccine Use in Younger People, Longer Refrigerator Storage
May 26, 2021
-
ORGANIZATION JPMA Positive on Use of Clinical Research Data in Submissions, but Wary of Funding Database
May 26, 2021
-
BUSINESS Flawed Stability Tests Found for 31 Choseido-Manufactured Products, Recalls Hit 15
May 25, 2021
-
REGULATORY MHLW Panel Backs Japan’s 1st Oncolytic Virus for Conditional Approval
May 25, 2021
-
BUSINESS Novartis Aims to Become Leader in Japan MS Market with Kesimpta Rollout
May 25, 2021
-
ORGANIZATION Ken Suzuki Likely to Come Back as JPWA Chief after 2 Years
May 25, 2021
-
BUSINESS Japan Ethical Drug Market Contracts 1% in Jan.-Mar.; Keytruda Top-Selling Drug for 8th Quarter Running: IQVIA
May 25, 2021
-
BUSINESS Janssen Seeks Japan Approval for COVID-19 Vaccine
May 24, 2021
-
REGULATORY MOF Panel’s Proposal Urges More Stringent Drug Cost Control, Revisiting of Semi-Automatic Listing
May 24, 2021
-
REGULATORY Biz Improvement Order Issued to 3 Codevelopers over Kobayashi Kako’s Fudged Data
May 24, 2021
-
REGULATORY PMDA Review Report: Flexible Discussions Needed for Eligibility of AstraZeneca Vaccine
May 24, 2021
-
ORGANIZATION JPMA Will Work towards Price Maintenance for On-Patent Medicines: New President
May 24, 2021
-
REGULATORY Japan Approves Moderna and AstraZeneca COVID-19 Vaccines
May 21, 2021
-
REGULATORY AstraZeneca, Moderna COVID-19 Vaccines in Line for Japan Approval on May 21
May 21, 2021
-
BUSINESS AbbVie Looks to Continue Double-Digit Annual Growth in New 5-Year Biz Plan
May 21, 2021
-
BUSINESS Janssen’s Darzquro, Chugai’s Polivy, JCR’s Izcargo Now Available in Japan
May 20, 2021
-
BUSINESS 5-Camp Battle Heating Up in HIF-PH Market; Evrenzo, Duvroq Neck-and-Neck for Top Spot
May 19, 2021
-
REGULATORY Pharma to Govt: Maintain Prices of Patented Drugs, It’s the Global Standard
May 18, 2021
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…